(Q35600523)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14656255%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

review article

1 reference

title

New and emerging drug therapies for the management of acute heart failure (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14656255%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

1 reference

acute decompensated heart failure

1 reference

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14656255%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

author name string

H Krum

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14656255%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

publication date

1 November 2003

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14656255%20AND%20SRC:MED&resulttype=core&format=json

Internal Medicine Journal

21 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14656255%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

volume

33

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14656255%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

issue

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14656255%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

page(s)

515-520

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14656255%20AND%20SRC:MED&resulttype=core&format=json

Nitrates in congestive heart failure.

21 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.1445-5994.2003.00483.X

Inotropic therapy for heart failure: an evidence-based approach.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1445-5994.2003.00483.X

Clinical benefit and approach of ultrafiltration in acute heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1445-5994.2003.00483.X

Surgical options for the treatment of heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1445-5994.2003.00483.X

Randomised controlled trial of continuous positive airway pressure and standard oxygen therapy in acute pulmonary oedema; effects on plasma brain natriuretic peptide concentrations

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1445-5994.2003.00483.X

Intravenous nesiritide, a natriuretic peptide, in the treatment of decompensated congestive heart failure. Nesiritide Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1445-5994.2003.00483.X

Comparison of the occurrence of ventricular arrhythmias in patients with acutely decompensated congestive heart failure receiving dobutamine versus nesiritide therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1445-5994.2003.00483.X

Mechanism of action of Ca2+ sensitizers--update 2001.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1445-5994.2003.00483.X

Levosimendan: a new era for inodilator therapy for heart failure?

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1445-5994.2003.00483.X

Safety and efficacy of a novel calcium sensitizer, levosimendan, in patients with left ventricular failure due to an acute myocardial infarction. A randomized, placebo-controlled, double-blind study (RUSSLAN).

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1445-5994.2003.00483.X

Efficacy and safety of intravenous levosimendan compared with dobutamine in severe low-output heart failure (the LIDO study): a randomised double-blind trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1445-5994.2003.00483.X

New therapeutics that antagonize endothelin: promises and frustrations

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1445-5994.2003.00483.X

The dual endothelin receptor antagonist tezosentan acutely improves hemodynamic parameters in patients with advanced heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1445-5994.2003.00483.X

Clinical trials update: highlights of the scientific sessions of the XXIII Congress of the European Society of Cardiology--WARIS II, ESCAMI, PAFAC, RITZ-1 and TIME

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1445-5994.2003.00483.X

Vasopressin: a new target for the treatment of heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1445-5994.2003.00483.X

New developments in the pharmacological treatment of chronic heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1445-5994.2003.00483.X

Clinical trials update: Highlights of the Scientific Sessions of Heart Failure 2001, a meeting of the Working Group on Heart Failure of the European Society of Cardiology. CONTAK-CD, CHRISTMAS, OPTIME-CHF

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1445-5994.2003.00483.X